National Drug Strategy
National Drug Strategy

Comorbidity of mental disorders and substance use: a brief guide for the primary care clinician

5. Depression and substance use

prev pageTOC |next page

Table of contents

5.1 Depression

5.2 Comorbidity with depression

5.3 Major clinical issues with depression and cannabis/hallucinogen use

5.4 Major clinical issues with depression and alcohol use

5.5 Major clinical issues with depression and opioid use

5.6 Major clinical issues with depression and stimulant (including methamphetamine) use

5.7 Major clinical issues with depression and benzodiazepine use

5.8 Major clinical issues with depression and inhalant/solvent use

prev pageTOC |next page